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Dendrimers are monodisperse, polybranched and polyfunctionalized polymers whose perfectly controlled synthesis affords isomolecular species with an adjusted
shape, nanometric size and equal disposition of organic moieties. They are able to enhance both the solubility and permeability of several drugs acting as
nanocarriers. However, their particular interest remains in the recent discovery of the biomedical applications that dendrimers display by themselves, with no drugs
associated. Hence, the aim of this report is to study a particular case of these innovative molecules, a phosphorus-containing dendrimer with implications in the
inflammation process, to finally propose it as a potential treatment of inflammatory disorders as Rheumatoid Arthritis.
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INTRODUCTION AND AIMS
CORE INTERIOR BRANCHING SURFACE GROUPS
STRUCTURE AND CLASSIFICATION OF DENDRIMERS
• Central initiator platform.
• Its valency determines the
branching degree and the final
surface group density.
• Small molecules, nanoparticles,
other dendrimers.
• Ethylenediamine, N3P3, PEO, etc.
• Robust, covalent structure.
• Generations.
• Connects core to surface groups.
• Chemical nature.
• Cationic, anionic, neutral.
• Hydrophobic surface.
• Target-directing groups.
• Multivalent electrostatic interac-
tions.
• Phosphonic acid, glucosamine,
carboxylic acid, etc.
Dendrimer 
families
All-amine All-amide PAMAM
Phosphorus-
containing
PEO
THE PHOSPHORUS-CONTAINING DENDRIMER ABP AND INFLAMMATION: STATE OF THE ART 
CONCLUSION
HUMAN MONOCYTES/MACROPHAGES TARGETING AND ACTIVATION
Poupot, M. (2006) Design of phosphorylated dendritic architectures to promote human monocyte activation. The FASEB Journal 20, 2339-2351.
• Phosphonic acid-capped FITC-derived phosphorus containing dendrimers cultured with PBMC.
• FRET showed that TLR2 of the monocyte/macrophage population is stimulated to emit fluorescence by the
fluorescent dendrimer.
• Internalization of the fluorescent dendrimer occurred only in the monocyte/macrophage population through a
phagolysosomial route. Phosphonic acids are more stable than phosphates and insensitive to phospholipases
and phosphatases.
• Macrophage activation measured by morphological and phenotipical changes of these cells.
• Best results of activation and stability given by the Azabisphosphonate-Capped Poly(phosphorhydrazone)
dendrimer or dendrimer ABP.
MACROPHAGE ACTIVATION
• Increased size and granulosity
• Changes in surface activation
markers
FITC-
dendrimer
Culture of monocytes/
macrophages expressing 
TLR2 and other PBMC
FRET Phagolysosomial
internalization
+ PBMC
http://www.wisegeek.com/what-are-monocytes.htm
http://www.andrewschemservices.com/
ANTI-INFLAMMATORY 
EFFECT OF 
DENDRIMER ABP
Fruchon, S. (2009) Anti-inflammatory and immunosuppressive
activation of human monocytes by a bioactive dendrimer. Jour-
nal Of Leukocyte Biology 85, 553-562.
Monocytes/Macrophages
CLASSICAL ACTIVATION
(INF-γ, LPS, TNF-α mediated)
ALTERNATIVE ACTIVATION
(IL-4, IL-10, IL-13 mediated)
Dendrimer ABP. Blue:
cyclo(triphosphazene)
core, black: phenoxy-
methylmethylhydrazone
branches, red: tyramine
based azabisphospho-
nate groups.
M1
(expressing IL-1, 
IL-6, IL-12, IL-13)
M2
(expressing IL-10, TGF-
β, PDGF, VEGF, EGF)
• Good APC
• Cytotoxicity
• Inflammation
• Tissue injury
• Poor APC
• Regulation
• Anti-inflammation
• Tissue repair
Hayder, M. Et al. (2011) Anti-
inflammatory properties of dendrimers
per se. The Scientific World Journal 11,
1367-1382.
ANTI-INFLAMMATORY AND ANTI-OSTEOCLASTIC PROPERTIES OF ABP IN THE TREATMENT OF RHEUMATOID ARTHRITIS
Hayder, M. (2011) A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis. Science Translational Medicine 3, 81ra35.
Rheumatoid Arthritis (RA) is an autoimmune inflammatory disease that affects approximately 1% of world population. It is characterized by inflammation of the joint synovial
membrane mediated by pro-inflammatory cytokines, cartilage degradation by Matrix Metallo Proteases (MMP) and subsequent bone erosion by osteoclasts.
12 weeks of weekly intravenously ABP treatment in IL-1ra-/- mice
Joint inflammation Cartilage degradation Bone erosion
• Normal, not swollen synovial
membrane.
• No infiltration of neutrophils, lym-
phocytes nor macrophages in the
synovial membrane.
• Increased secretion of anti-inflam-
matory cytokines and decreased secre-
tion of pro-inflammatory cytokines.
• Normal cartilage collagen appearance.
• Decreased amounts of of MMP-3 and
MMP-9 enzymes.
• No osteoclasts presence in the bone
matrix.
• ABP inhibits the differentiation of mono-
cytes/macrophages into osteoclasts.
Approximation
of dendrimer
ABP activity in
the inhibition
of osteoclast
differentiation
from a bone
marrow ma-
crophage.
Davignon, J.-L. et al. (2013)
Targeting monocytes
/macrophages in the
treatment of Rheumatoid
Arthritis. Rheumatology 52,
590-598.
DENDRIMER ABP PROPERTIES
IN VITRO
Monocytes/ma-
crophages
targeting through 
TLR-2
Phagolysosomial
internalization of 
monocytes/ma-
crophages
Alternative activation 
of macrophages: M2 & 
anti-inflamma-tory 
response
IN VIVO
(RA mice model)
Inhibits osteoclast 
differentiation: No 
bone erosion
No joint 
inflammation
No cartilage 
degradation
DENDRIMER ABP IS A POTENTIAL DRUG IN THE TREATMENT OF BOTH CHRONIC AND ACUTE INFLAMMATORY DISORDERS
